Regeneron Pharmaceuticals


Regeneron Halts Covid-19 Trial For High-Flow Oxygen Patients; Shares Fall

Regeneron Pharmaceuticals (REGN) has revealed that the independent data monitoring committee (IDMC) has advised it to modify its current REGN-COV2 antibody cocktail treatment trials …

Sanofi, Regeneron’s Dupixent Significantly Reduces Children’s Asthma Attacks

Sanofi (SNYNF) and Regeneron have announced that a pivotal Phase 3 trial of Dupixent (dupilumab) met its primary and all key secondary endpoints in children …

Regeneron Prices $1.25B Public Offering; Analyst Cautious On Valuation

Regeneron Pharmaceuticals (REGN) has now announced the pricing of an underwritten offering of $1.250 billion aggregate principal amount of senior unsecured notes due …

Company Update (NASDAQ:REGN): Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi SA (ADR) (NYSE:SNY) announced that the European Medicine Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) …

Company Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc Aids in New Film Documenting Stories of People Living with High LDL Cholesterol

Managing cholesterol is a private, emotional fight against a condition that cannot be seen or felt.1 Now, a new film highlights individuals around …

Stock Update (NASDAQ:REGN): Regerneron Pharmaceuticals Inc EYLEA® (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that Bayer HealthCare’sJapanese subsidiary, Bayer Yakuhin, Ltd., received approval for EYLEA® (aflibercept) Injection by the Ministry of Health, Labour and …

Stock Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc Announces 2015 Winners of the Regeneron Prize for Creative Innovation

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced the winners of the third annual Regeneron Prize for Creative Innovation, an award designed to acknowledge, reward and foster talented …

Company Update (NASDAQ:REGN): Trading in Regeneron Pharmaceuticals Inc Common Stock Halted

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that NASDAQ has halted trading of the company’s common stock.  The Endocrinologic and Metabolic Drugs Advisory Committee of the …

Stock Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc and Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi announced that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary …

Deutsche Bank Maintains Buy On Regeneron Following Discussion With CEO

In a research report sent to investors today, Deutsche Bank analyst Robyn Karnauskas maintained a Buy rating on Regeneron Pharmaceuticals (NASDAQ:REGN) with a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts